Data / Drug companies / Schedule II
Companies that list Schedule II controlled substances: 196 companies and 2,232 products in the FDA NDC directory
The FDA National Drug Code Directory lists 2,232 products that are Schedule II controlled substances from 196 companies. The ten largest listers hold 31.3% of them, and the newest started marketing on October 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 196
- Products
- 2,232
- Drugs by generic name
- 59
- Main marketing category
- Generic drugs (ANDA)
Companies with the most Schedule II products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| SpecGx LLC | 140 | powder; tablet | Generic drugs (ANDA) | August 28, 2025 |
| Bryant Ranch Prepack | 89 | tablet; capsule, extended release | Generic drugs (ANDA) | May 3, 2024 |
| Bryant Ranch Prepack | 89 | tablet; capsule, extended release | Generic drugs (ANDA) | February 11, 2021 |
| Bryant Ranch Prepack | 73 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | September 10, 2024 |
| Camber Pharmaceuticals, Inc. | 69 | tablet; capsule, extended release | Generic drugs (ANDA) | November 14, 2025 |
| Rhodes Pharmaceuticals LLC | 54 | tablet; capsule, extended release | Generic drugs (ANDA) | January 30, 2024 |
| Lannett Company, Inc. | 52 | capsule, extended release; tablet | Generic drugs (ANDA) | February 22, 2024 |
| Granules Pharmaceuticals Inc. | 50 | capsule, extended release; tablet | Generic drugs (ANDA) | January 29, 2025 |
| Societal Cdmo Gainesville, LLC | 42 | capsule, extended release | Drugs for further processing | June 1, 2025 |
| Amneal Pharmaceuticals of New York LLC | 40 | capsule, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 5, 2018 |
| Cambrex Charles City, Inc | 39 | powder; liquid | Bulk ingredients | June 28, 2022 |
| Hikma Pharmaceuticals USA Inc. | 39 | tablet; solution | Generic drugs (ANDA) | December 15, 2025 |
| Aurolife Pharma, LLC | 37 | tablet; solution | Generic drugs (ANDA) | January 27, 2020 |
| Alvogen Inc. | 36 | tablet; tablet, extended release | Generic drugs (ANDA) | August 25, 2023 |
| KVK-Tech, Inc. | 35 | tablet; solution | Generic drugs (ANDA) | December 5, 2019 |
| Lupin Pharmaceuticals,Inc. | 35 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | June 12, 2017 |
| Sun Pharmaceutical Industries, Inc. | 33 | tablet; capsule | Generic drugs (ANDA) | December 20, 2024 |
| XLCare Pharmaceuticals, Inc. | 32 | tablet; tablet, extended release | Generic drugs (ANDA) | September 24, 2020 |
| Elite Laboratories, Inc. | 30 | tablet; capsule | Generic drugs (ANDA) | November 15, 2024 |
| Sandoz Inc | 29 | capsule, extended release; capsule | Authorized generics (NDA) | October 1, 2026 |
| Epic Pharma, LLC | 28 | tablet; tablet, film coated | Generic drugs (ANDA) | December 31, 2021 |
| Hikma Pharmaceuticals USA Inc. | 28 | injection; injection, solution | Generic drugs (ANDA) | August 29, 2025 |
| Veranova, L.P. | 28 | powder | Bulk ingredients | January 8, 2026 |
| Asclemed USA, Inc. | 25 | tablet | Generic drugs (ANDA) | September 10, 2024 |
| American Health Packaging | 24 | tablet; solution | Generic drugs (ANDA) | September 9, 2026 |
| Teva Pharmaceuticals, Inc. | 23 | capsule; tablet, orally disintegrating | Generic drugs (ANDA) | December 8, 2025 |
| Direct_Rx | 21 | tablet | Generic drugs (ANDA) | November 25, 2025 |
| Hospira, Inc. | 21 | injection, solution | New drug applications (NDA) | April 21, 2025 |
| Chattem Chemicals, Inc. | 20 | powder; liquid | Bulk ingredients | June 29, 2023 |
| Mylan Pharmaceuticals Inc. | 19 | patch; capsule | Generic drugs (ANDA) | August 25, 2023 |
| St. Mary's Medical Park Pharmacy | 19 | tablet | Generic drugs (ANDA) | August 6, 2026 |
| Cranbury Pharmaceuticals, LLC | 18 | tablet; solution | Generic drugs (ANDA) | August 20, 2022 |
| Catalent Pharma Solutions, LLC | 16 | capsule; capsule, extended release | Drugs for further processing | April 23, 2024 |
| Fresenius Kabi USA, LLC | 16 | injection, solution; injection, powder, lyophilized, for solution | New drug applications (NDA) | January 15, 2021 |
| Professional Compounding Centers of America DBA Pcca | 16 | powder | Bulk ingredients for compounding | December 1, 2025 |
| Siegfried USA, LLC | 16 | powder | Bulk ingredients | November 22, 2023 |
| Padagis US LLC | 15 | suppository; tablet, extended release | Other unapproved drugs | June 5, 2023 |
| Azurity Pharmaceuticals, Inc. | 14 | tablet; solution | Generic drugs (ANDA) | March 20, 2026 |
| Eywa Pharma Inc | 14 | tablet; solution | Generic drugs (ANDA) | June 17, 2019 |
| Redpharm Drug | 14 | tablet; solution | Generic drugs (ANDA) | September 10, 2024 |
| Sandoz Inc | 14 | capsule, extended release; tablet | New drug applications (NDA) | May 31, 2005 |
| Amneal Pharmaceuticals LLC | 13 | tablet; capsule | Generic drugs (ANDA) | August 28, 2023 |
| Collegium Pharmaceutical, Inc. | 13 | capsule, extended release; tablet, film coated, extended release | New drug applications (NDA) | April 19, 2019 |
| Knoa Pharma LLC | 13 | tablet, film coated, extended release; tablet, extended release | New drug applications (NDA) | January 15, 2015 |
| NuCare Pharmaceuticals,Inc. | 13 | tablet | Generic drugs (ANDA) | July 13, 2018 |
| Takeda Pharmaceuticals America, Inc. | 13 | capsule; tablet, chewable | New drug applications (NDA) | January 28, 2017 |
| Actavis Pharma, Inc. | 12 | capsule, extended release | Generic drugs (ANDA) | February 4, 2014 |
| Ascend Laboratories, LLC | 12 | tablet; solution | Generic drugs (ANDA) | July 1, 2025 |
| Golden State Medical Supply, Inc. | 12 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | November 26, 2021 |
| Major Pharmaceuticals | 12 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | January 3, 2024 |
| NextWave Pharmaceuticals, Inc | 12 | suspension, extended release; tablet, extended release | New drug applications (NDA) | November 4, 2021 |
| NorthStar Rx LLC | 12 | tablet | Generic drugs (ANDA) | March 20, 2019 |
| Solco Healthcare US, LLC | 12 | capsule; tablet | Generic drugs (ANDA) | August 26, 2023 |
| Adare Pharmaceuticals Inc | 11 | capsule; tablet, orally disintegrating | Drugs for further processing | May 16, 2019 |
| Medisca Inc. | 11 | powder | Bulk ingredients for compounding | August 9, 2017 |
| Patheon Manufacturing Services LLC | 11 | tablet; capsule | Drugs for further processing | December 18, 2017 |
| Proficient Rx LP | 11 | tablet | Generic drugs (ANDA) | December 1, 2016 |
| Trigen Laboratories, LLC | 11 | tablet, extended release | Generic drugs (ANDA) | June 23, 2022 |
| American Health Packaging | 10 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | February 25, 2020 |
| Amneal Pharmaceuticals LLC | 10 | tablet, film coated, extended release; capsule, extended release | Generic drugs (ANDA) | January 2, 2013 |
| Takeda Pharmaceuticals America, Inc. | 10 | capsule, extended release | New drug applications (NDA) | June 20, 2017 |
| Winder Laboratories LLC | 10 | tablet; solution | Generic drugs (ANDA) | December 6, 2021 |
| Asclemed USA Inc. | 9 | tablet | Generic drugs (ANDA) | June 1, 2019 |
| Fresenius Kabi USA, LLC | 9 | injection, solution | New drug applications (NDA) | December 4, 2018 |
| Neos Therapeutics Brands, LLC | 9 | tablet, orally disintegrating | New drug applications (NDA) | June 20, 2017 |
| Neos Therapeutics, LP | 9 | tablet, orally disintegrating | Authorized generics (NDA) | July 1, 2026 |
| Noramco, LLC | 9 | powder | Bulk ingredients | December 10, 2021 |
| Novadoz Pharmaceuticals LLC | 9 | tablet, chewable; tablet, film coated | Generic drugs (ANDA) | September 3, 2026 |
| Precision Dose, Inc. | 9 | solution; tablet | New drug applications (NDA) | September 1, 2025 |
| Spectrum Laboratory Products, Inc. | 9 | powder; crystal | Bulk ingredients | January 1, 2002 |
| Strides Pharma Science Limited | 9 | tablet | Generic drugs (ANDA) | September 1, 2025 |
| Sunrise Pharmaceutical, Inc. | 9 | tablet | Generic drugs (ANDA) | July 4, 2018 |
| Teva Pharmaceuticals USA, Inc. | 9 | tablet | Generic drugs (ANDA) | March 19, 2003 |
| Upsher-Smith Laboratories, LLC | 9 | capsule, extended release; tablet | Generic drugs (ANDA) | July 22, 2019 |
| Amneal Pharmaceuticals of New York LLC | 8 | tablet | Generic drugs (ANDA) | February 18, 2010 |
| Ascent Pharmaceuticals, Inc. | 8 | solution; tablet | Generic drugs (ANDA) | January 29, 2021 |
| Aveva Drug Delivery Systems Inc. | 8 | patch, extended release | Generic drugs (ANDA) | February 11, 2025 |
| Curia New York, Inc. | 8 | powder | Bulk ingredients | May 2, 2018 |
| Ingenus Pharmaceuticals, LLC | 8 | patch, extended release | Generic drugs (ANDA) | February 11, 2025 |
| Novartis Pharmaceuticals Corporation | 8 | capsule, extended release | New drug applications (NDA) | May 31, 2005 |
| Noven Therapeutics, LLC | 8 | patch, extended release; patch | New drug applications (NDA) | May 15, 2023 |
| Pai Holdings, LLC DBA Pai Pharma | 8 | solution | Generic drugs (ANDA) | September 15, 2025 |
| Par Health USA, LLC | 8 | capsule, extended release | Generic drugs (ANDA) | January 5, 2017 |
| Pharma Source Direct, LLC. | 8 | powder | Bulk ingredients | June 1, 2022 |
| Teva Pharmaceuticals USA, Inc. | 8 | capsule, extended release | Generic drugs (ANDA) | July 5, 2017 |
| Actavis Pharma, Inc. | 7 | capsule, extended release | Generic drugs (ANDA) | September 30, 2020 |
| Apotex Corp. | 7 | capsule | Generic drugs (ANDA) | November 9, 2023 |
| Genus Lifesciences | 7 | solution; tablet | Generic drugs (ANDA) | May 15, 2026 |
| Prasco Laboratories | 7 | capsule, extended release; solution | Authorized generics (NDA) | May 15, 2014 |
| Teva Pharmaceuticals USA, Inc. | 7 | tablet | Generic drugs (ANDA) | March 3, 2015 |
| Vertical Pharmaceuticals, LLC | 7 | tablet, extended release | New drug applications (NDA) | June 23, 2022 |
| VistaPharm, LLC | 7 | tablet; concentrate | Generic drugs (ANDA) | September 11, 2020 |
| Wilshire Pharmaceuticals, Inc. | 7 | tablet | Generic drugs (ANDA) | August 6, 2021 |
| Ani Pharmaceuticals, Inc. | 6 | capsule, extended release | Generic drugs (ANDA) | March 16, 2020 |
| AvKARE | 6 | capsule | Generic drugs (ANDA) | June 4, 2025 |
| AvPAK | 6 | tablet | Generic drugs (ANDA) | July 9, 2018 |
| Aytu BioPharma, Inc. | 6 | capsule, extended release | New drug applications (NDA) | February 22, 2024 |
| Burel Pharmaceuticals, LLC | 6 | capsule, extended release | Generic drugs (ANDA) | December 16, 2019 |
| Dr. Reddy's Laboratories Inc. | 6 | capsule, extended release; tablet | Generic drugs (ANDA) | November 7, 2025 |
| Letco Medical, LLC | 6 | powder | Bulk ingredients for compounding | May 14, 2015 |
Drugs most often listed
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.